Treatment of glioblastoma multiforme: A new standard

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations


Glioblastoma multiforme is one of the most lethal and treatment-resistant of human tumors. Among the therapeutic triad of surgery, radiation therapy, and chemotherapy, only radiation therapy has been shown to improve survival. 1 Despite 30 years of intensive efforts to find an effective chemotherapy regimen for glioblastoma multiforme, the median survival of 12 to 15 months has not changed appreciably since the introduction of radiation therapy.

Original languageEnglish (US)
Pages (from-to)337-341
Number of pages5
JournalArchives of Neurology
Issue number3
StatePublished - Mar 2006
Externally publishedYes

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology


Dive into the research topics of 'Treatment of glioblastoma multiforme: A new standard'. Together they form a unique fingerprint.

Cite this